Teva Pharmaceutical Industries Limited (NYSE: TEVA)
Teva Pharmaceutical Industries Limited
Stock Symbol: NYSE: TEVA
Class Period Start: 08/04/2017
Class Period End (inclusive): 08/04/2017
Filing Deadline: 08/20/2019
Court: Eastern District of Pennsylvania
The law firm of Barbuto & Johansson, P.A., and Director of Client Relations Neil Rothstein, Esq. remind investors that they have until August 20th, 2019 to file lead plaintiff applications in a securities class action lawsuit against Teva Pharmaceutical Industries.
Teva Pharmaceutical and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 10, 2019, an antitrust lawsuit against the Company was filed by an alliance of 44 state Attorneys General highlighting facts about its role as a “consistent participant” in a generic drug price-fixing conspiracy involving price increases for more than 110 generic drugs.
On this news, the price of Teva Pharmaceutical’s ADS plummeted by nearly 15%.
If you purchased securities of Teva Pharmaceutical and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, please contact one of our attorneys. Call the firm today at (561) 444-7980 and/or fill out the form to the right.
The case is Employees’ Retirement System of The City of St. Petersburg, Florida v. Teva Pharmaceutical, 19-cv-2711. Click here for full case complaint.